Importantly, we found that RBM15 expression was associated with patient survival in basal-like BC/TNBC patients, indicating that the prognostic effects of RBM15 are not solely driven by tumor subtype (Fig. 1j, k, and Supplementary Fig. 8). This evidence concerns the gene RBM15 and breast cancer.